Roundup of renal cancer research

February 19, 2019

Dr Toni Choueiri speaks to ecancer at the 2019 ASCO Genitourinary Cancers Symposium providing highlights from the renal cancer research at year's conference. He provides data from some of the most important studies, and emerging combinations in renal cancer. The remainder of Dr Choueiri's highlights cover MET inhibitors and PDL-1 inhibitors in non-clear cell renal carcinoma.

Spotlight

Sight Diagnostics

The faster we diagnose, the faster we can treat. At Sight Diagnostics, we aim to improve health through fast, accurate and convenient diagnostic testing.

OTHER VIDEOS

What are some the key trends in Healthcare Informatics in 2023?

video | December 5, 2022

Healthcare Informatics is fast transforming the healthcare industry into a data-driven one, providing both healthcare workers and patients with detailed insights to make better medical decisions....

Watch Now

Capgemini World Life and Health Insurance Report 2022

video | December 3, 2022

With the growing interest amongst customers regarding physical and financial wellness, the inaugural edition of the Capgemini World Life and Health Insurance Report 2022...

Watch Now

Developing Future-Ready Healthcare Professionals

video | December 5, 2022

“As healthcare professionals ourselves, we need to be agile to shape not just our current healthcare practices but also the future needs of our generation”,...

Watch Now

What are cataracts? Causes, diagnosis and treatment explained

video | December 5, 2022

Dr Fayyaz Musa, Consultant Eye Surgeon, says cataracts occur when the crystalline lens inside the eye becomes cloudy and is most commonly caused by ageing, however it can also be caused by steroid usage or diabetes....

Watch Now

Spotlight

Sight Diagnostics

The faster we diagnose, the faster we can treat. At Sight Diagnostics, we aim to improve health through fast, accurate and convenient diagnostic testing.

Events